Canada markets closed

Defence Therapeutics Inc. (DTCFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.56430.0000 (0.00%)
At close: 02:53PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 84.16M
Enterprise Value 81.94M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)40.88
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -14.02

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 32.57%
S&P500 52-Week Change 3-0.65%
52 Week High 36.4078
52 Week Low 32.5000
50-Day Moving Average 32.9512
200-Day Moving Average 34.1459

Share Statistics

Avg Vol (3 month) 3106
Avg Vol (10 day) 335
Shares Outstanding 536.05M
Implied Shares Outstanding 6N/A
Float 834.14M
% Held by Insiders 15.99%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Jun 29, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-69.70%
Return on Equity (ttm)-116.80%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-5.85M
Diluted EPS (ttm)-0.1370
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.85M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.11
Book Value Per Share (mrq)0.08

Cash Flow Statement

Operating Cash Flow (ttm)-5.04M
Levered Free Cash Flow (ttm)-2.81M